Monday, January 17, 2022 9:34:03 AM
Jan 17, 2022 • 20 minutes ago • < 1 minute read •
OTTAWA — Canada has approved Pfizer Inc’s COVID-19 oral antiviral treatment, the Canadian Broadcasting Corp said on Monday, citing sources, and said an announcement could be made later in the day.
Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators. (Reporting by David Ljunggren)
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM